Follow
Dalal Abou El Ella
Dalal Abou El Ella
Faculty of Pharmacy, Ain Shams University
Verified email at pharma.asu.edu.eg
Title
Cited by
Cited by
Year
Design and Synthesis of New Tetrazolyl- and Carboxy-biphenylylmethyl-quinazolin-4-one Derivatives as Angiotensin II AT1 Receptor Antagonists
MAH Ismail, S Barker, DA Abou El Ella, KAM Abouzid, RA Toubar, ...
Journal of medicinal chemistry 49 (5), 1526-1535, 2006
1422006
1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: synthesis and in vitro biological evaluation
SM Abou-Seri, WM Eldehna, MM Ali, DA Abou El Ella
European journal of medicinal chemistry 107, 165-179, 2016
1262016
Molecular modeling study and synthesis of novel pyrrolo [2, 3-d] pyrimidines and pyrrolotriazolopyrimidines of expected antitumor and radioprotective activities
DA Abou El Ella, MM Ghorab, E Noaman, HI Heiba, AI Khalil
Bioorganic & medicinal chemistry 16 (5), 2391-2402, 2008
1002008
Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agents
RSM Ismail, NSM Ismail, S Abuserii, DA Abou El Ella
Future Journal of Pharmaceutical Sciences 2 (1), 9-19, 2016
922016
Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1 …
WM Eldehna, SM Abou-Seri, AM El Kerdawy, RR Ayyad, AM Hamdy, ...
European Journal of Medicinal Chemistry 113, 50-62, 2016
842016
Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII
WM Eldehna, M Fares, M Ceruso, HA Ghabbour, SM Abou-Seri, ...
European journal of medicinal chemistry 110, 259-266, 2016
832016
Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold
MI Shahin, DA Abou El Ella, NSM Ismail, KAM Abouzid
Bioorganic Chemistry 56, 16-26, 2014
762014
Design, synthesis, mechanistic studies and in silico ADME predictions of benzimidazole derivatives as novel antifungal agents
MM Morcoss, MN El Shimaa, RA Ibrahem, HM Abdel-Rahman, ...
Bioorganic chemistry 101, 103956, 2020
722020
Quinoxaline‐based scaffolds targeting tyrosine kinases and their potential anticancer activity
AMS El Newahie, NSM Ismail, DA Abou El Ella, KAM Abouzid
Archiv der Pharmazie 349 (5), 309-326, 2016
682016
Thieno [2, 3-d] pyrimidine based derivatives as kinase inhibitors and anticancer agents
EZ Elrazaz, RAT Serya, NSM Ismail, DA Abou El Ella, KAM Abouzid
Future Journal of Pharmaceutical Sciences 1 (2), 33-41, 2015
682015
Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking
WM Eldehna, M Fares, HS Ibrahim, MH Aly, S Zada, MM Ali, ...
European journal of medicinal chemistry 100, 89-97, 2015
622015
Pyrazolo [3, 4-d] pyrimidine based scaffold derivatives targeting kinases as anticancer agents
NSM Ismail, EMH Ali, DA Ibrahim, RAT Serya, DA Abou El Ella
Future Journal of Pharmaceutical Sciences 2 (1), 20-30, 2016
592016
Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide …
MM Ghorab, MS Alsaid, N Samir, GA Abdel-Latif, AM Soliman, FA Ragab, ...
European journal of medicinal chemistry 134, 304-315, 2017
572017
Design and synthesis of new quinoxaline derivatives as anticancer agents and apoptotic inducers
AMS El Newahie, YM Nissan, NSM Ismail, DA Abou El Ella, SM Khojah, ...
Molecules 24 (6), 1175, 2019
542019
Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII
DA Ibrahim, DS Lasheen, MY Zaky, AW Ibrahim, D Vullo, M Ceruso, ...
Bioorganic & medicinal chemistry 23 (15), 4989-4999, 2015
532015
Molecular modeling study and synthesis of quinazolinone-arylpiperazine derivatives as α1-adrenoreceptor antagonists
SM Abou-Seri, K Abouzid, DA Abou El Ella
European Journal of Medicinal Chemistry 46 (2), 647-658, 2011
532011
Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells
RSM Ismail, SM Abou-Seri, WM Eldehna, NSM Ismail, SM Elgazwi, ...
European Journal of Medicinal Chemistry 155, 782-796, 2018
522018
Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers
MM Ghorab, MS Alsaid, GH Al-Ansary, GA Abdel-Latif, DA Abou El Ella
European journal of medicinal chemistry 124, 946-958, 2016
502016
Lonazolac analogues: molecular modeling, synthesis, and in vivo anti-inflammatory activity
MAH Ismail, J Lehmann, DA Abou El Ella, A Albohy, KAM Abouzid
Medicinal chemistry research 18, 725-744, 2009
462009
Novel quinoline-3-carboxamides (Part 2): Design, optimization and synthesis of quinoline based scaffold as EGFR inhibitors with potent anticancer activity
RM Aly, RAT Serya, AM El-Motwally, A Esmat, S Abbas, DA Abou El Ella
Bioorganic Chemistry 75, 368-392, 2017
452017
The system can't perform the operation now. Try again later.
Articles 1–20